| Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells H Bugaut, M Bruchard, H Berger, V Derangère, L Odoul, R Euvrard, ... PLoS One 8 (6), e65181, 2013 | 124 | 2013 |
| SOCS3 transactivation by PPARγ prevents IL-17–driven cancer growth H Berger, F Végran, M Chikh, F Gilardi, S Ladoire, H Bugaut, G Mignot, ... Cancer research 73 (12), 3578-3590, 2013 | 61 | 2013 |
| Neutrophil–Platelet and Monocyte–Platelet Aggregates in COVID-19 Patients A Le Joncour, L Biard, M Vautier, H Bugaut, A Mekinian, G Maalouf, ... Thrombosis and Haemostasis, 2020 | 55 | 2020 |
| Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis G Elourimi, M Soussan, U Warzocha, H Bugaud, R Dhôte, S Abad Rheumatology International 37 (11), 1931-1935, 2017 | 12 | 2017 |
| Immune ambivalence: The schizophrenic bleomycin G Mignot, H Bugaut, F Ghiringhelli Oncoimmunology 2 (9), e25737, 2013 | 4 | 2013 |
| Progressive pigmented purpuric dermatosis and platelet delta storage pool deficiency in a child V Gkalea, S Tang, R Favier, C Kuadjovi, E Bégon, H Bugaut, JC Bordet, ... Pediatric blood & cancer 66 (7), e27748, 2019 | 1 | 2019 |
